An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.

NCT00307619 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Binge Eating

Interventions

DRUG: topiramate

Sponsor

Janssen-Cilag Farmaceutica Ltda.